PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10496984-0	1999	Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.	Dermatan Sulfate	178-194	plasminogen	Homo sapiens	251-258	
15203110-5	2004	Heparin, heparan sulfate and dermatan sulfate, at various HARP to glycosaminoglycan ratios, partially protect HARP from plasmin degradation.	Dermatan Sulfate	29-45	plasminogen	Homo sapiens	120-127	
7225714-2	1981	2 Only dermatan sulphate preparations of considerable heparin content potentiate AT III inhibition of thrombin, factor Xa and plasmin.	Dermatan Sulfate	7-24	plasminogen	Homo sapiens	126-133	
27564657-8	2016	Dermatan sulfate and polyphosphates with sodium as counter ion (Na-PolyP700, Na-PolyP100 and Na-PolyP70) enhanced plasmin-mediated but not thrombin-mediated TAFI activation.	Dermatan Sulfate	0-16	plasminogen	Homo sapiens	114-121	
17270255-8	2007	The facilitation of the conversion of Glu-plasminogen to plasmin in the presence of DS was confirmed by SDS-PAGE; high molecular weight-DS effect was greater than low molecular weight-DS in accordance with the chromogenic assays.	Dermatan Sulfate	84-86	plasminogen	Homo sapiens	42-49